Loading clinical trials...
Loading clinical trials...
Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Conditions
Interventions
Neridronic acid 100 mg
Placebo
Locations
71
United States
US015 - Tennessee Valley Pain Consultants
Huntsville, Alabama, United States
US043 - Horizon Research Partners
Mobile, Alabama, United States
US045 - Holland Center for Family Health
Peoria, Arizona, United States
US003 - HealthStar Research
Hot Springs, Arkansas, United States
US049 - Orange County Research Institute
Anaheim, California, United States
US053 - Core Healthcare Group
Cerritos, California, United States
Start Date
May 30, 2018
Primary Completion Date
July 31, 2019
Completion Date
July 31, 2019
Last Updated
August 6, 2020
Lead Sponsor
Grünenthal GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions